Menu Back toTransforming-Informed-Consent-Current-Landscape-and-Tools-to-Enable-the-Future-of-eConsent

DIA 2018 Global Annual Meeting


Implementation of eConsent and Other Digital Clinical Trial Innovations

    Session Chair(s)
      Jennifer  Lentz

      Jennifer Lentz

      • Consultant, Global Informed Business Lead
      • Eli Lilly and Company, United States
    Learn about using eConsent in the informed consent process. Insight will be shared into understanding how eConsent may be used to improve the consent process; how this may impact sites, IRBs, and sponsors; and how the use of eConsent may impact the patient experience. Finally, attendees will learn how to use other digital tech innovations to advance patient centricities.
    Learning Objective : 1. Patient Centricity: Learn how modernized unified data platforms are supporting stakeholders flexibility to advance patient centricity powered digital tech innovations. 2. Accelerate Study Design: Learn how to reduce study build times and execution throughout all phases of clinical trials by up to 50%. 3. Improve Data Quality: Gain knowledge to architect a trial to reduce mid-study change risks
    Speaker(s)
      Jennifer  Lentz

      Transforming Informed Consent: Current Landscape and Tools to Enable the Future of eConsent

      Jennifer Lentz

      • Consultant, Global Informed Business Lead
      • Eli Lilly and Company, United States
      MaryAnne  Rizk, PhD

      Driving Clinical Outsourcing Innovation Forward with Machine Learning: Self-Driving Systems to Automate and Accelerate

      MaryAnne Rizk, PhD

      • Vice President, Global BioPharma Partnerships
      • Oracle, United States
      Eric  Delente, MA

      eConsent: A Patient-Centric Program to Improve Enrollment, Recruitment, and Retention

      Eric Delente, MA

      • President, Patient Solutions
      • DrugDev, United States
      Cami  Gearhart, JD

      Are Your Sites Prepared for eConsent?

      Cami Gearhart, JD

      • CEO
      • Quorum Review, United States